HBM Healthcare Investments AG Stock
Equities
HBMN
CH0012627250
Investment Management & Fund Operators
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
208 CHF | +0.73% | +0.97% | +13.91% |
May. 28 | HBM Healthcare Flags NAV Boost from Yellow Jersey-Johnson & Johnson Deal | MT |
May. 23 | HBM Healthcare Investments' Portfolio Company to Buy Laboratorios Biopas Group | MT |
Sales 2025 * | 76.9M 85.17M | Sales 2026 * | 132M 147M | Capitalization | 1.44B 1.59B |
---|---|---|---|---|---|
Net income 2025 * | 51M 56.49M | Net income 2026 * | 107M 119M | EV / Sales 2025 * | 17.2 x |
Net cash position 2025 * | 117M 130M | Net cash position 2026 * | 126M 140M | EV / Sales 2026 * | 9.91 x |
P/E ratio 2025 * |
28.7
x | P/E ratio 2026 * |
13.6
x | Employees | 700 |
Yield 2025 * |
3.46% | Yield 2026 * |
3.81% | Free-Float | 82.11% |
1 day | +0.73% | ||
1 week | +0.97% | ||
1 month | +11.59% | ||
3 months | +13.17% | ||
6 months | +18.86% | ||
Current year | +13.91% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Wicki
CEO | Chief Executive Officer | 64 | 01-06-30 |
Erwin Troxler
DFI | Director of Finance/CFO | 54 | 11-10-31 |
Benedikt Suter
SEC | Corporate Secretary | 60 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 09-05-31 | |
Elaine Jones
BRD | Director/Board Member | 69 | 21-06-17 |
Mario Giuliani
BRD | Director/Board Member | 52 | 11-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 208 | +0.73% | 3,805 |
24-05-30 | 206.5 | +1.47% | 3,642 |
24-05-29 | 203.5 | -1.93% | 3,666 |
24-05-28 | 207.5 | +1.47% | 6,523 |
24-05-27 | 204.5 | -0.73% | 2,979 |
Delayed Quote Swiss Exchange, May 31, 2024 at 11:30 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.91% | 1.59B | |
+18.42% | 3.16B | |
+12.82% | 1.77B | |
-11.54% | 1.21B | |
+19.42% | 793M | |
+10.61% | 674M | |
+30.96% | 561M | |
-4.17% | 506M | |
+34.78% | 489M | |
+70.93% | 316M |
- Stock Market
- Equities
- HBMN Stock